#BEGIN_DRUGCARD DB04164

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C13H23NO7

# Chemical_IUPAC_Name:
(1R,2S,3R,6R)-6-{[(2R,3R,4S,5S)-4,5-dihydroxy-2-methyloxan-3-yl]amino}-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose

# HET_ID:
DAF

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C13H23NO7/c1-5-9(12(19)8(16)4-21-5)14-7-2-6(3-15)10(17)13(20)11(7)18/h2,5,7-20H,3-4H2,1H3/t5-,7-,8+,9+,10-,11-,12-,13+/m1/s1

# InChI_Key:
InChIKey=LTAGIBUDYBSPEG-HCDBHUNCSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4164

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
305.3242

# Molecular_Weight_Mono:
305.147452095

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1G94

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.1

# Predicted_LogS:
-0.27

# Predicted_Water_Solubility:
1.64e+02 g/l

# Primary_Accession_No:
DB04164

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936908

# PubChem_Substance_ID:
46504993

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01105

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@H]1OC[C@H](O)[C@@H](O)[C@H]1N[C@@H]1C=C(CO)[C@@H](O)[C@H](O)[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:01 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X58627

# Drug_Target_1_GenBank_ID_Protein:
2879820

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
amy

# Drug_Target_1_Gene_Sequence:
>2010 bp
ATGAAACTCAATAAAATAATCACCACCGCAGGTTTAAGCCTAGGGTTGCTCTTACCTAGC
ATTGCGACTGCTACGCCCACCACATTTGTACATTTGTTTGAATGGAATTGGCAAGATGTA
GCGCAAGAATGTGAGCAATACCTAGGACCAAAAGGCTACGCTGCAGTACAGGTCTCGCCA
CCTAATGAGCACATTACAGGAAGCCAATGGTGGACACGTTATCAGCCAGTAAGTTATGAA
CTGCAAAGTCGTGGCGGAAACCGTGCACAGTTTATCGATATGGTAAATCGCTGTAGTGCA
GCTGGGGTTGATATTTACGTTGATACGCTTATTAACCATATGGCAGCAGGAAGTGGCACA
GGCACGGCGGGAAATAGCTTTGGTAATAAAAGCTTTCCTATTTATAGCCCACAAGATTTT
CATGAAAGTTGTACCATTAATAACTCTGATTATGGCAACGATCGCTACCGAGTACAAAAC
TGTGAACTAGTTGGACTTGCCGATTTAGATACCGCTTCAAACTATGTGCAAAATACCATT
GCAGCATATATTAACGACTTACAAGCTATTGGCGTAAAAGGCTTTCGGTTTGATGCTTCT
AAACATGTTGCAGCAAGCGATATCCAAAGTTTAATGGCCAAAGTAAATGGCTCGCCAGTG
GTTTTTCAAGAAGTGATCGATCAAGGTGGGGAGGCTGTTGGTGCCTCTGAATATTTAAGC
ACAGGTTTAGTAACTGAATTTAAATATAGCACTGAGCTTGGTAACACTTTTAGAAACGGC
TCGCTTGCATGGCTGAGTAATTTTGGCGAAGGGTGGGGCTTTATGCCAAGCTCTTCTGCG
GTGGTTTTTGTAGACAATCACGACAATCAGCGCGGGCACGGCGGCGCTGGCAATGTTATT
ACCTTTGAAGATGGCCGCTTATATGACTTAGCCAATGTATTTATGTTGGCTTATCCGTAC
GGTTATCCAAAAGTAATGTCGAGTTATGATTTTCATGGTGATACAGATGCTGGTGGGCCA
AATGTACCGGTACATAATAATGGTAACTTAGAGTGTTTTGCGAGTAATTGGAAGTGTGAG
CATCGCTGGTCATATATTGCAGGCGGGGTCGATTTTAGAAATAACACCGCCGACAACTGG
GCAGTAACAAATTGGTGGGATAACACAAATAATCAAATTTCATTTGGCCGAGGTAGCTCG
GGTCATATGGCTATTAACAAAGAAGACTCAACACTTACTGCAACTGTGCAAACCGATATG
GCGTCAGGGCAATACTGTAATGTGCTAAAAGGCGAACTGTCAGCTGATGCTAAAAGTTGT
AGTGGTGAGGTTATAACGGTTAATTCCGACGGTACTATTAATCTTAATATTGGCGCTTGG
GATGCGATGGCAATTCATAAAAATGCCAAGTTAAATACCAGTTCTGCCTCAAGCACTGAA
AGTGACTGGCAGCGAACGGTTATTTTTATTAATGCACAAACACAAAGCGGACAAGATATG
TTTATCCGTGGTGGAATTGACCACGCTTATGCAAACGCAAACCTTGGTCGAAATTGCCAA
ACAAGTAATTTTGAGTGTGCAATGCCTATTCGTCATAACAATTTAAAAAATGTCACAACA
AGCCCTTGGAAAGCAAATGATAACTACCTTGATTGGTATGGTATAGAAAATGGGCAAAGT
AGCGAAGCAGAAGGTTCTGCTACCGACTGGACAACGAACGTTTGGCCAGCAGGTTGGGGC
GCTGAAAAAACGGTAAACACAGATGGTTTTGGTGTGACACCTTTAAATATATGGGGCGAA
CACTATTGGATGCTTGATGTAGATATGGATTGCAGTAAAGCGGTTAATGGATGGTTTGAA
CTAAAAGCATTCATTAAAAATGGCCAAGGATGGGAGACTGCCATTGCACAAGACAATGCA
CCTTATACAAGTACTAATCATATGGCGCAATGCGGAAAAATTAATAAATTTGAGTTTAAT
AATTCAGGTGTAGTAATTCGTAGTTTTTAA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
1544904	Feller G, Lonhienne T, Deroanne C, Libioulle C, Van Beeumen J, Gerday C: Purification, characterization, and nucleotide sequence of the thermolabile alpha-amylase from the antarctic psychrotroph Alteromonas haloplanctis A23. J Biol Chem. 1992 Mar 15;267(8):5217-21.
9541387	Aghajari N, Feller G, Gerday C, Haser R: Crystal structures of the psychrophilic alpha-amylase from Alteromonas haloplanctis in its native form and complexed with an inhibitor. Protein Sci. 1998 Mar;7(3):564-72.
9575155	Feller G, D'Amico S, Benotmane AM, Joly F, Van Beeumen J, Gerday C: Characterization of the C-terminal propeptide involved in bacterial wall spanning of alpha-amylase from the psychrophile Alteromonas haloplanctis. J Biol Chem. 1998 May 15;273(20):12109-15.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2948

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
73268

# Drug_Target_1_Name:
Alpha-amylase

# Drug_Target_1_Number_of_Residues:
669

# Drug_Target_1_PDB_ID:
1B0I

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00128	Alpha-amylase
PF02806	Alpha-amylase_C

# Drug_Target_1_Protein_Sequence:
>Alpha-amylase precursor
MKLNKIITTAGLSLGLLLPSIATATPTTFVHLFEWNWQDVAQECEQYLGPKGYAAVQVSP
PNEHITGSQWWTRYQPVSYELQSRGGNRAQFIDMVNRCSAAGVDIYVDTLINHMAAGSGT
GTAGNSFGNKSFPIYSPQDFHESCTINNSDYGNDRYRVQNCELVGLADLDTASNYVQNTI
AAYINDLQAIGVKGFRFDASKHVAASDIQSLMAKVNGSPVVFQEVIDQGGEAVGASEYLS
TGLVTEFKYSTELGNTFRNGSLAWLSNFGEGWGFMPSSSAVVFVDNHDNQRGHGGAGNVI
TFEDGRLYDLANVFMLAYPYGYPKVMSSYDFHGDTDAGGPNVPVHNNGNLECFASNWKCE
HRWSYIAGGVDFRNNTADNWAVTNWWDNTNNQISFGRGSSGHMAINKEDSTLTATVQTDM
ASGQYCNVLKGELSADAKSCSGEVITVNSDGTINLNIGAWDAMAIHKNAKLNTSSASSTE
SDWQRTVIFINAQTQSGQDMFIRGGIDHAYANANLGRNCQTSNFECAMPIRHNNLKNVTT
SPWKANDNYLDWYGIENGQSSEAEGSATDWTTNVWPAGWGAEKTVNTDGFGVTPLNIWGE
HYWMLDVDMDCSKAVNGWFELKAFIKNGQGWETAIAQDNAPYTSTNHMAQCGKINKFEFN
NSGVVIRSF

# Drug_Target_1_Reaction:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in polysaccharides containing three or more 1,4-alpha-linked D-glucose units ALL_REAC (other) R02108 R06209(G)

# Drug_Target_1_Signals:
1-24

# Drug_Target_1_Specific_Function:
Endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides and polysaccharides

# Drug_Target_1_SwissProt_ID:
P29957

# Drug_Target_1_SwissProt_Name:
AMY_PSEHA

# Drug_Target_1_Synonyms:
1,4-alpha-D-glucan glucanohydrolase
Alpha-amylase precursor
EC 3.2.1.1

# Drug_Target_1_Theoretical_pI:
4.70

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04164
